Microbial communities in the respiratory tract of patients with interstitial lung disease

Thorax

Volumn 68, Issue 12, 2013, Pages 1150-1156

  Garzoni, Christian ^a,b   Brugger, Silvio D ^a   Qi, Weihong ^c   Wasmer, Sarah ^a   Cusini, Alexia ^a   Dumont, Philippe ^a,d   Gorgievski Hrisoho, Meri ^a   Mühlemann, Kathrin ^a   Garnier, Christophe Von ^a   Hilty, Markus ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b Reparto di Chirurgia Ortopedica   (Switzerland)

^c UNIVERSITY OF ZURICH   (Switzerland)

^d Hopital Cantonal de Fribourg   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

RNA 16S;

16S RRNA GENE; ACIDAMINOCOCCACEAE; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE SEQUENCE; HUMAN; IMMUNOCOMPROMISED PATIENT; INTERSTITIAL LUNG DISEASE; INTERSTITIAL PNEUMONIA; LOWER RESPIRATORY TRACT; LUNG SARCOIDOSIS; MALE; MICROBIAL COMMUNITY; MICROBIAL DIVERSITY; NONHUMAN; NUCLEOTIDE SEQUENCE; PNEUMOCYSTIS PNEUMONIA; POLYMERASE CHAIN REACTION; PREVOTELLACEAE; PRIORITY JOURNAL; PYROSEQUENCING; STREPTOCOCCACEAE; UPPER RESPIRATORY TRACT;

BACTERIAL INFECTION; IMMUNODEFICIENCY; RESPIRATORY INFECTION; SARCOIDOSIS;

ADULT; AGED; BACTERIA; BACTEROIDETES; BRONCHOALVEOLAR LAVAGE FLUID; CASE-CONTROL STUDIES; FEMALE; HUMANS; IDIOPATHIC INTERSTITIAL PNEUMONIAS; MALE; MICROBIOTA; MIDDLE AGED; PNEUMONIA, PNEUMOCYSTIS; RESPIRATORY SYSTEM; RNA, RIBOSOMAL, 16S; SARCOIDOSIS, PULMONARY; STREPTOCOCCACEAE; VEILLONELLACEAE;

EID: 84887435078     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2012-202917     Document Type: Article

References (33)

1. Laurenzi GA, Potter RT, Kass EH. Bacteriologic flora of the lower respiratory tract. N Engl J Med 1961;265:1273-8
2. Pecora DV. A comparison of transtracheal aspiration with other methods of determining the bacterial flora of the lower respiratory tract. N Engl J Med 1963;269:664-6
3. Hilty M, Burke C, Pedro H, et al. Disordered microbial communities in asthmatic airways. PLoS One 2010;5:e8578
4. Charlson ES, Bittinger K, Haas AR, et al. Topographical continuity of bacterial populations in the healthy human respiratory tract. Am J Respir Crit Care Med 2011;184:957-63
5. Erb-Downward JR, Thompson DL, Han MK, et al. Analysis of the lung microbiome in the "healthy" smoker and in COPD. PLoS One 2011;6:e16384
6. Han MK, Huang YJ, Lipuma JJ, et al. Significance of the microbiome in obstructive lung disease. Thorax 2012;67:456-63
7. Pragman AA, Kim HB, Reilly CS, et al. The lung microbiome in moderate and severe chronic obstructive pulmonary disease. PLoS One 2012;7:e47305
8. Sze MA, Dimitriu PA, Hayashi S, et al. The lung tissue microbiome in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2012;185:1073-80
9. Carroll KC. Laboratory diagnosis of lower respiratory tract infections: controversy and conundrums. J Clin Microbiol 2002;40:3115-20 (Pubitemid 34977416)
10. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med 2002; 165.277-304.
11. Iwai S, Fei M, Huang D,, et al Oral and airway microbiota in HIV-infected pneumonia patients. J Clin Microbiol 2012;50:2995-3002
12. Jakobsson HE, Jernberg C, Andersson AF, et al. Short-term antibiotic treatment has differing long-term impacts on the human throat and gut microbiome. PLoS One 2010;5:e9836
13. Garcia LS. Clinical microbiology procedures handbook. 3rd edn. ASM Press, 2010
14. Muhlethaler K, Bogli-Stuber K, Wasmer S, et al. Quantitative PCR to diagnose Pneumocystis pneumonia in immunocompromised non-HIV patients. Eur Respir J 2012;39:971-8
15. Brugger SD, Frei L, Frey PM, et al. 16S rRNA terminal restriction fragment length polymorphism for the characterization of the nasopharyngeal microbiota. PLoS One 2012;7:e52241
16. Brugger SD, Hathaway LJ, Muhlemann K. Detection of Streptococcus pneumoniae strain cocolonization in the nasopharynx. J Clin Microbiol 2009;47:1750-6
17. Hilty M, Qi W, Brugger SD, et al. Nasopharyngeal microbiota in infants with acute otitis media. J Infect Dis 2012;205:1048-55
18. Kunin V, Hugenholtz P. PyroTagger: a fast, accurate pipeline for analysis of rRNA amplicon pyrosequence data. The Open Journal 2010:1-8
19. Schloss PD, Westcott SL, Ryabin T, et al. Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities. Appl Environ Microbiol 2009;75:7537-41
20. Frank DN, Feazel LM, Bessesen MT, et al. The human nasal microbiota and Staphylococcus aureus carriage. PLoS One 2010;5:e10598
21. King P. Haemophilus influenzae and the lung (Haemophilus and the lung). Clin Transl Med 2012;1:10
22. Cardenas PA, Cooper PJ, Cox MJ, et al. Upper airways microbiota in antibiotic-naive wheezing and healthy infants from the tropics of rural Ecuador. PLoS One 2012;7: e46803
23. Rogers GB, van der Gast CJ, Cuthbertson L, et al. Clinical measures of disease in adult non-CF bronchiectasis correlate with airway microbiota composition. Thorax 2013;68:731-7
24. Lipuma JJ. The changing microbial epidemiology in cystic fibrosis. Clin Microbiol Rev 2010;23:299-323
25. Rogers GB, Hoffman LR, Carroll MP, et al. Interpreting infective microbiota: the importance of an ecological perspective. Trends Microbiol 2013;21:271-6
26. Goddard AF, Staudinger BJ, Dowd SE, et al. Direct sampling of cystic fibrosis lungs indicates that DNA-based analyses of upper-airway specimens can misrepresent lung microbiota. Proc Natl Acad Sci USA 2012;109:13769-74
27. Willner D, Haynes MR, Furlan M, et al. Spatial distribution of microbial communities in the cystic fibrosis lung. ISME J 2012;6:471-4
28. Bousbia S, Papazian L, Auffray JP, et al. Tropheryma whipplei in patients with pneumonia. Emerg Infect Dis 2010;16:258-63
29. Harris JK, De Groote MA, Sagel SD, et al. Molecular identification of bacteria in bronchoalveolar lavage fluid from children with cystic fibrosis. Proc Natl Acad Sci U S A 2007;104:20529-33
30. Duff RM, Simmonds NJ, Davies JC, et al. A molecular comparison of microbial communities in bronchiectasis and cystic fibrosis. Eur Respir J 2013; 41:991-3
31. Charlson ES, Diamond JM, Bittinger K, et al. Lung-enriched organisms and aberrant bacterial and fungal respiratory microbiota following lung transplant. Am J Respir Crit Care Med 2012;186:536-45
32. Stressmann FA, Rogers GB, van der Gast CJ, et al. Long-term cultivation-independent microbial diversity analysis demonstrates that bacterial communities infecting the adult cystic fibrosis lung show stability and resilience. Thorax 2012;67:867-73
33. Zhao J, Schloss PD, Kalikin LM, et al. Decade-long bacterial community dynamics in cystic fibrosis airways. Proc Natl Acad Sci USA 2012;109:5809-14.